Flex, a Sketch-to-Scale® solutions provider, has gathered a clinical advisory board to leverage the perspectives of leading doctors for the development of powerful digital health solutions that integrate into and improve clinical workflow to make a real-world impact on patient outcomes. Flex’s BrightInsight Clinical Board, consisting of leading clinicians support Flex Digital Health in developing and improving its digital health solutions, which emphasize digital therapeutics that integrate into and improve clinical workflow with the goal of making a real-world impact on patient outcomes.
“As we continue to develop leading-edge digital health solutions, it’s paramount that we keep clinical workflow and the clinician’s point-of-view top of mind,” said Kal Patel, M.D. and SVP of Digital Health at Flex. “Although we are seeing a proliferation of effective digital health solutions coming to market, they almost universally lack integration into the health care professional’s clinical workflow. Without this integration, these solutions will not be able to achieve scale and deliver upon their promise to make a clinical and economic impact at the population level. We are honored to be working with leading clinicians to help us tackle these challenges.”
Flex’s Digital Health business will get advice from the Brightsight Clinical Board – from concept to commercialization – to ensure advancements in three core areas: clinical workflow integration, designing solutions that engage patients in self- care, and facilitating the capture of clinically-relevant data and analytics.
Flex is the Sketch-to-Scale® solutions provider that designs and builds Intelligent Products for a Connected World®. With approximately 200,000 professionals across 30 countries, Flex provides innovative design, engineering, manufacturing, real-time supply chain insight and logistics services to companies of all sizes in various industries and end-markets.
The members of the advisory board include:
Steven Edelman, M.D., a professor of medicine in the Division of Endocrinology, Diabetes & Metabolism at the University of California at San Diego and the Veterans Affairs Healthcare System of San Diego, and the director of the Diabetes Care Clinic, VA Medical Center.
Tania Elliott, M.D., FAAAAI, FACAAI, faculty member at NYU Langone Health and is a national spokesperson for the American College of Allergy, Asthma, and Immunology. Dr. Elliott is a nationally-recognized leader in telemedicine, serving as first author for a position paper on telemedicine for Allergists and having previously worked for Doctor on Demand where she saw thousands of patients through real-time face-to-face video consultations while recruiting and training top physicians around the country.
Arturo Loaiza-Bonilla, M.D., MSEd, FACP, the current Vice Chairman of the Department of Medical Oncology at Cancer Treatment Centers of America, Chief of Medical Oncology and Medical Director of Research at CTCA – Philadelphia, and Co-Founder and Chief Medical Officer at Massive Bio.
Steven Steinhubl, M.D., an Associate Professor of Genomic Medicine at Scripps Research, a clinical cardiologist and the Director of Digital Medicine at the Scripps Research Translational Institute.